Skip to content

The Safety and Efficacy of an Artificial Intelligence-Guided Virtual Contrast-Enhanced CT Strategy in the Diagnosis of Emergency Abdominal Pain: A Randomized, Crossover Validation Clinical Trial

The Safety and Efficacy of an Artificial Intelligence-Guided Virtual Contrast-Enhanced CT Strategy in the Diagnosis of Emergency Abdominal Pain: A Randomized, Crossover Validation Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120450
Enrollment
Unknown
Registered
2026-03-15
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:Radiologists' Diagnosis Based on NCCT + vCECT Four radiologists were divided into two groups, rotating diagnostic strategies every two weeks, with each patients images evaluated usi
Control group:Radiologists use non-contrast CT scans for diagnosis
Four radiologists were divided into two groups, rotating diagnostic strategies every two weeks, with each patients images evaluated using both strategies simultaneously.

Sponsors

Changhai Hospital, The Navy Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: Patients aged >=18 years at the time of enrollment; 2. Clinical presentation: Acute non-traumatic abdominal pain within 3 days of onset; 3. Clinical indication: Clinical decision for emergency abdominal CT imaging based on the assessment of the emergency physician; 4. Suspected disease: Clinically suspected of having one or more of the following five target diseases: acute appendicitis, intestinal obstruction (including strangulated intestinal obstruction), acute pancreatitis with suspected pancreatic necrosis, acute cholecystitis, acute vascular disease (aortic dissection, abdominal aortic aneurysm, acute mesenteric ischemia/thrombosis); 5. Informed consent: Able and willing to provide written informed consent; 6. Follow-up feasibility: Expected to be reachable for 30-day follow-up.

Exclusion criteria

Exclusion criteria: 1.Medical Exclusion Criteria: Hemodynamic instability, critical/severe life-threatening conditions, pregnancy, recent relevant imaging studies, contraindications to CT examination. 2.Technical Exclusion Criteria: History of abdominal surgery, metal implants. 3.Administrative Exclusion Criteria: Inability to provide informed consent, restrictions affecting follow-up.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy;

Secondary

MeasureTime frame
Diagnostic time;Safety;Emergency Department Length of Stay (ED LOS) ;Diagnostic performance (lesion detection sensitivity, specificity, positive predictive value, negative predictive value, AUC, negative likelihood ratio);

Countries

China

Contacts

Public ContactYun Bian

Changhai Hospital, The Navy Military Medical University

bianyun2012@foxmail.com+86 138 1635 7024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026